What the Parity Law Says About Addiction Coverage

What does the parity law actually require?

The Mental Health Parity and Addiction Equity Act of 2008, usually shortened to MHPAEA, requires that when a health plan chooses to cover mental-health and substance-use benefits, it cannot impose more restrictive financial requirements or treatment limits on that care than it applies to medical and surgical benefits 1Ref 1Centers for Medicare & Medicaid Services (2024).Mental Health Parity and Addiction Equity Act (MHPAEA).MHPAEA (2008) requires plans covering mental-health/substance-use benefits not to impose more restrictive financial requirements or treatment limitations than for medical/surgical benefits, and does not itself mandate that a plan cover SUD treatment.. The core word is comparable. A plan is allowed to charge a copay for a therapy visit; it is not allowed to charge a higher copay for a therapy visit than for a primary-care visit. It can require prior authorization; it cannot require prior authorization for addiction care while waving through the comparable medical service without it.

Parity is a comparison rule, not a coverage mandate — it governs how addiction care is covered, never whether it is.

The law reaches most employer plans and Marketplace plans, and later rules extended similar protections into Medicaid and CHIP 2Ref 2Centers for Medicare & Medicaid Services / Medicaid.gov (2024).Parity — Behavioral Health Services.How federal parity requirements apply within Medicaid and CHIP, including managed-care plans, for mental-health and substance-use benefits.. It grew out of a simple, documented pattern: plans that covered a broken leg without a second thought would cap the same member at a handful of counseling sessions, or demand paperwork for every week of addiction treatment. Parity made that unequal treatment the thing a regulator can act on.

What parity does not do

Parity does not make a plan cover addiction treatment, and it does not cap what you pay. This is the gap that surprises families. MHPAEA only governs the terms a plan uses for the substance-use benefits it already offers; it does not itself require a plan to offer them 1Ref 1Centers for Medicare & Medicaid Services (2024).Mental Health Parity and Addiction Equity Act (MHPAEA).MHPAEA (2008) requires plans covering mental-health/substance-use benefits not to impose more restrictive financial requirements or treatment limitations than for medical/surgical benefits, and does not itself mandate that a plan cover SUD treatment.. If a plan genuinely covers no residential addiction care for anyone, there is no medical-surgical benchmark to compare against, and parity has nothing to grab onto.

So a large medical bill is not, by itself, a parity violation. A high deductible is not a violation if the deductible is the same one that applies to your surgeries. Parity is violated only when the plan treats the behavioral-health benefit worse than the medical one. Understanding how insurance coverage for rehab works in your specific plan — the deductible, the network, the level-of-care rules — matters just as much as knowing your parity rights, because most of what you will actually pay is set by the ordinary structure of the plan, not by anything parity forbids.

Financial limits versus treatment limits

Parity covers two families of rules, and denials tend to hide in the second one. The first family is financial: copays, coinsurance, deductibles, and out-of-pocket maximums. These are the easy comparisons — a number against a number.

The second family is treatment limitations, and it splits again. Quantitative treatment limitations are countable: a limit of so many visits or so many covered days. Non-quantitative treatment limitations, often the harder fight, are the judgment-based rules — prior authorization requirements, medical-necessity criteria, step-therapy 'fail first' policies, and how a plan decides what counts as the right level of care. Parity requires that these non-quantitative rules be written and applied no more stringently for addiction care than for comparable medical care 1Ref 1Centers for Medicare & Medicaid Services (2024).Mental Health Parity and Addiction Equity Act (MHPAEA).MHPAEA (2008) requires plans covering mental-health/substance-use benefits not to impose more restrictive financial requirements or treatment limitations than for medical/surgical benefits, and does not itself mandate that a plan cover SUD treatment..

When a plan approves week one of treatment and then denies week two after a utilization review, the fight is almost always in that third row.

How parity applies to Medicaid and CHIP

Parity protections extend into Medicaid and the Children's Health Insurance Program, though the mechanics differ from commercial insurance 2Ref 2Centers for Medicare & Medicaid Services / Medicaid.gov (2024).Parity — Behavioral Health Services.How federal parity requirements apply within Medicaid and CHIP, including managed-care plans, for mental-health and substance-use benefits.. Most people on Medicaid receive their benefits through managed-care organizations, and federal parity rules require those plans to apply comparable standards to mental-health and substance-use benefits 2Ref 2Centers for Medicare & Medicaid Services / Medicaid.gov (2024).Parity — Behavioral Health Services.How federal parity requirements apply within Medicaid and CHIP, including managed-care plans, for mental-health and substance-use benefits.. The practical upshot is the same principle: an addiction benefit inside a Medicaid managed-care plan cannot carry tighter limits or heavier prior-authorization burdens than the medical benefits in the same plan.

The details of how a state runs its program vary, so the exact benefit and the appeal path are things to confirm with the state Medicaid agency or the managed-care plan directly. But the underlying protection travels with you: parity is not only a private-insurance idea.

How to recognize a possible parity violation

A parity problem usually looks like a rule that is stricter for addiction care than for the medical care beside it. Because parity is a comparison, the useful question is never 'is this restriction fair?' but 'would my plan do this for a comparable medical condition?' A few patterns come up again and again:

• A day-limit or visit-limit on behavioral-health care that has no equivalent on comparable medical care.
• A prior-authorization or 'fail first' requirement demanded for addiction treatment but not for the comparable medical service.
• Medical-necessity criteria that are dramatically narrower for substance-use care, so coverage is cut off at a level a physical-health patient would keep.
• A blanket exclusion of medication-assisted treatment, when the plan covers comparable maintenance medications for other chronic conditions.

You have a right to ask the plan, in writing, for the criteria it used to deny your claim and for the comparable medical-surgical standard. If the two do not match, that discrepancy is the heart of a parity complaint. Appealing a rehab coverage denial is a defined process with internal and external steps, and the parity comparison is often the strongest argument inside it.

Where parity meets the marketing problem

Knowing your parity rights matters more because the addiction-treatment marketplace has a documented deception problem, and a confused, desperate buyer is exactly who it targets. Federal oversight has recorded patient-brokering schemes and kickbacks for referrals in the treatment industry 3Ref 3U.S. House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations (2018).Examining Concerns of Patient Brokering and Addiction Treatment Fraud.Patient brokering and addiction-treatment fraud, including kickbacks for referrals, were the subject of federal Congressional oversight., and enforcers now act against deceptive rehab marketing under a dedicated law — the Opioid Addiction Recovery Fraud Prevention Act of 2018 — which produced a $1.9 million settlement against one marketer for misleading people seeking care 4Ref 4Federal Trade Commission (2025).Enforcing the Opioid Addiction Recovery Fraud Prevention Act: The FTC's settlement with Evoke Wellness.The Opioid Addiction Recovery Fraud Prevention Act (2018) gives the FTC authority against deceptive substance-use-treatment marketing, and a $1.9M settlement resulted..

One concrete guardrail: ad platforms now require addiction-treatment advertisers to hold LegitScript certification before they can run search ads 5Ref 5Google (2024).Healthcare and medicines — Advertising Policies Help.Ad platforms require addiction-treatment advertisers to be LegitScript-certified before they can advertise.. LegitScript verifies a program's licensing, staff qualifications, and disclosure of any legal or regulatory history 6Ref 6LegitScript (2024).Addiction Treatment Certification.LegitScript certification verifies a program's licensing, staff qualifications, and disclosure of legal/regulatory history, and is the standard ad platforms require.. That does not make an ad an endorsement, but the absence of certification on a paid ad is a signal worth noticing. When you are ready to look for care, the neutral place to start is the government's own directory rather than a sponsored 'helpline': SAMHSA maintains official treatment locators 7Ref 7Substance Abuse and Mental Health Services Administration (2024).Treatment Locators: Mental Health, Drug, Alcohol Issues.SAMHSA maintains official government treatment locators, a neutral referral source rather than a commercial helpline., and FindTreatment.gov is a free, confidential, anonymous search of state-licensed facilities 8Ref 8Substance Abuse and Mental Health Services Administration (2024).FindTreatment.gov.FindTreatment.gov is the federal government's free, confidential, anonymous locator of state-licensed treatment facilities..

Parity and medication for opioid use disorder

One of the sharpest places parity gets tested is coverage for medication that treats opioid use disorder, because the clinical standard is clear and plan limits often are not. The national guideline of record recommends treating opioid use disorder with methadone or buprenorphine rather than withdrawal management alone, holds that no medication should be withheld because of a person's ongoing use of other substances, and says the medication should not be arbitrarily time-limited 10Ref 10American Society of Addiction Medicine (2020).The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder — 2020 Focused Update.The guideline recommends treating opioid use disorder with methadone or buprenorphine rather than withdrawal management alone, that no medication be withheld because of ongoing use of other substances, and that medication not be arbitrarily time-limited.. That is what medication-assisted treatment looks like when it follows the evidence.

Set that against how plans sometimes behave: a cap on how many months they will cover buprenorphine, a requirement to attend counseling as a precondition for the medication, or a 'fail first' rule. Each of those is worth examining through the parity lens, because an arbitrary time limit or precondition on addiction medication may not match how the plan treats maintenance medication for other chronic conditions. Methadone itself is dispensed through opioid treatment programs regulated federally under 42 CFR Part 8, and a 2024 final rule expanded access — allowing more take-home doses, telehealth initiation, and removing a prior requirement that a person have a full year of addiction before admission 11Ref 11Substance Abuse and Mental Health Services Administration (2024).42 CFR Part 8 Final Rule.Opioid treatment programs dispensing methadone are federally regulated under 42 CFR Part 8, and the 2024 final rule expanded access, including take-home doses, telehealth initiation, and removing the prior one-year-of-addiction admission requirement.. Knowing the clinical standard and the federal rule gives you two firm benchmarks a parity argument can lean on.

What to do if you think your plan is violating parity

If a denial looks like it fails the parity comparison, the move is to document, request, and appeal rather than to pay quietly. First, get the denial in writing and ask the plan for both the medical-necessity criteria it applied and the comparable medical-surgical standard. Second, file the plan's internal appeal within its deadline, naming the parity discrepancy directly. Third, if the internal appeal fails, most plans owe you an independent external review.

Parity complaints can also go to a regulator: the U.S. Department of Labor for most employer plans, or your state insurance department for state-regulated ones. None of this changes the underlying clinical picture — substance use disorders and other mental-health conditions frequently co-occur, and effective care generally addresses both at once rather than one after the other 9Ref 9National Institute on Drug Abuse (2024).Co-Occurring Disorders and Health Conditions.Substance use disorders and other mental illnesses frequently co-occur and treatment should address both conditions concurrently.. Coverage that arbitrarily severs the two is precisely the kind of unequal treatment parity was written to reach.

The treatment gap the law was meant to close

Parity exists because of a stubborn gap: for years, far more people needed substance-use treatment than received it, and unequal insurance coverage was one reason why. National survey data continue to show that a large share of people who could benefit from substance-use treatment do not get it 12Ref 12Substance Abuse and Mental Health Services Administration (2024).Key Substance Use and Mental Health Indicators in the United States: Results from the 2023 National Survey on Drug Use and Health.A large share of people who need substance-use treatment do not receive it, evidencing a substantial national treatment gap.. Coverage is not the only barrier — stigma, geography, and simple not-knowing-where-to-start all play a part — but a plan that treats addiction care worse than medical care makes the gap wider by design.

That is the frame worth keeping. Parity is not a guarantee that care will be easy to get or cheap; it is a legal floor under how your plan treats addiction relative to everything else it covers. Used well — knowing what to ask for, what to compare it against, and how to appeal — it is a real tool for closing the distance between needing care and actually reaching it. And when you are ready to look, starting from a neutral government locator rather than a sponsored ad keeps the search honest from the first click.